LeonaBio, Inc. Proceeds from Short-term Debt, Maturing in Three Months or Less
LeonaBio, Inc. (LONA) reported Proceeds from Short-term Debt, Maturing in Three Months or Less of $215.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebtMaturingInThreeMonthsOrLess · last filed 2020-11-12
- 2020-09-30: Proceeds from Short-term Debt, Maturing in Three Months or Less 9 month $215.00K.
| Period end | Proceeds from Short-term Debt, Maturing in Three Months or Less 9 month |
|---|---|
| 2020-09-30 | $215.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |